GRAS Notices
-
GRN No. 758
Lactobacillus helveticus R0052, Bifidobacterium longum subsp. infantis R0033, and Bifidobacterium bifidum R0071
Intended Use: | For use, both individually and in combination, as an ingredient of powdered infant formulas at 5 x 107 cfu/g of powder in formulas with hydration rates of 12.5 to 13/5 g/100 ml. |
---|---|
Basis: | Scientific procedures |
Notifier: | Lallemand Health Solutions |
Notifier Address: |
17975 rue des Gouverneurs Mirabel, Quebec, J7J 2K7 Canada |
GRAS Notice (releasable information): | GRN 758 (in PDF) (5.0 MB) |
Part 2: | GRN 758 amendments (in PDF) (630 kB) |
Date of closure: | Aug 20, 2018 |
FDA's Letter: | FDA has no questions (in PDF) (103 kB) |
-